Brain Advance Access originally published online on June 30, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Brain, Vol. 127, No. 9, 2031-2038,
September 2004
© 2004 Guarantors of Brain
doi: 10.1093/brain/awh223
The influence of genetic and cardiovascular risk factors on the CADASIL phenotype
1 Clinical Neuroscience, St George's Hospital Medical School and 2 Neuroradiology, Atkinson Morley Neuroscience Centre, St George's Hospital, London, UK
Correspondence to: Professor Hugh Markus, Clinical Neuroscience, St George's Hospital Medical School, Cranmer Terrace, London SW17 0RE, UK E-mail: h.markus{at}sghms.ac.uk
The clinical phenotype in cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL), an autosomal dominant cerebral arteriopathy, is variable, but the reasons for this remain uncertain. Possible factors include the mutation site and the influence of additional modulating factors, which could include both epistatic interactions and interactions with cardiovascular risk factors known to cause sporadic small vessel disease. In a large prospectively recruited cohort of CADASIL subjects we determined relationships between phenotype and mutation site, the apoE genotype and cardiovascular risk factors. In addition to clinical features, disease severity was assessed by MRI lesion volume, measured both semiquantitatively (Scheltens scale) and quantitatively. One hundred and twenty-seven CADASIL cases from 65 families with 17 different mutations were studied. Site of mutation was not associated with the presence or age of onset of stroke, migraine, dementia, dependency or MRI lesion load. There was no evidence of intrafamilial clustering of particular phenotypes. Amongst subjects with stroke/transient ischaemic attack, smoking at the time of the event was independently associated with earlier age of onset (P = 0.01). There were no associations between age of onset or presence of stroke and other cardiovascular risk factors, including homocysteine. Homocysteine levels were higher in migraineurs [mean (SD) 12.8 (5.6) versus 9.8 (3.4) µmol/l, P = 0.02)] and elevated homocysteine was independently associated with an earlier age of onset of migraine (P = 0.01). No relationship was found between MRI lesion volume and risk factors, or between apoE genotype and phenotype. Our results show no notch 3 genotype–phenotype correlations. This implies that modulating factors influence phenotype. Smoking appears to increase the risk of stroke, while high homocysteine levels are associated with an increased risk of migraine.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. H. Taylor and G. A. Doody CADASIL: a guide to a comparatively unrecognised condition in psychiatry Advan. Psychiatr. Treat., September 1, 2008; 14(5): 350 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.A. Kempster and J.E. Alty John Ruskin's relapsing encephalopathy Brain, September 1, 2008; 131(9): 2520 - 2525. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Stenborg, H. Kalimo, M. Viitanen, A. Terent, and L. Lind Impaired Endothelial Function of Forearm Resistance Arteries in CADASIL Patients Stroke, October 1, 2007; 38(10): 2692 - 2697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Liem, J. van der Grond, J. Haan, R. van den Boom, M. D. Ferrari, Y. M. Knaap, M. H. Breuning, M. A. van Buchem, H. A.M. Middelkoop, and S. A.J. Lesnik Oberstein Lacunar Infarcts Are the Main Correlate With Cognitive Dysfunction in CADASIL Stroke, March 1, 2007; 38(3): 923 - 928. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Rufa, F. Guideri, M. Acampa, G. Cevenini, S. Bianchi, N. De Stefano, M. L. Stromillo, A. Federico, and M. T. Dotti Cardiac Autonomic Nervous System and Risk of Arrhythmias in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Stroke, February 1, 2007; 38(2): 276 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Choi, S.-Y. Kang, J.-H. Kang, and J.-K. Park Intracerebral hemorrhages in CADASIL Neurology, December 12, 2006; 67(11): 2042 - 2044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Opherk, N. Peters, M. Holtmannspotter, A. Gschwendtner, B. Muller-Myhsok, and M. Dichgans Heritability of MRI Lesion Volume in CADASIL: Evidence for Genetic Modifiers Stroke, November 1, 2006; 37(11): 2684 - 2689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Viswanathan, J.-P. Guichard, A. Gschwendtner, F. Buffon, R. Cumurcuic, C. Boutron, E. Vicaut, M. Holtmannspotter, C. Pachai, M.-G. Bousser, et al. Blood pressure and haemoglobin A1c are associated with microhaemorrhage in CADASIL: a two-centre cohort study Brain, September 1, 2006; 129(9): 2375 - 2383. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Cumurciuc, P. Henry, C. Gobron, E. Vicaut, M.-G. Bousser, H. Chabriat, and K. Vahedi Electrocardiogram in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy Patients Without Any Clinical Evidence of Coronary Artery Disease: A Case-Control Study Stroke, April 1, 2006; 37(4): 1100 - 1102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. van den Boom, S.A.J. Lesnick Oberstein, A.A. van den Berg-Huysmans, M.D. Ferrari, M.A. van Buchem, and J. Haan Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy: Structural MR Imaging Changes and Apolipoprotein E Genotype. AJNR Am. J. Neuroradiol., February 1, 2006; 27(2): 359 - 362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. S. Markus and M. J. Alberts Update on Genetics of Stroke and Cerebrovascular Disease 2005 Stroke, February 1, 2006; 37(2): 288 - 290. [Full Text] [PDF]
|
|
|
|
|
|
G. G. Leblanc, J. F. Meschia, D. T. Stuss, and V. Hachinski Genetics of Vascular Cognitive Impairment: The Opportunity and the Challenges Stroke, January 1, 2006; 37(1): 248 - 255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Rufa, M. T. Dotti, M. Franchi, M. L. Stromillo, G. Cevenini, S. Bianchi, N. De Stefano, and A. Federico Systemic Blood Pressure Profile in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy Stroke, December 1, 2005; 36(12): 2554 - 2558. [Abstract] [Full Text] [PDF]
|
|